Specialty Ophthalmology
-
Featured
Researchers Find Potential Path to a Broadly Protective COVID-19 Vaccine Using T cells
Gaurav Gaiha, MD, DPhil, and Elizabeth Rossin, MD, PhD, use structure-based network analysis to confirm predictions about the potential for a T cell vaccine that provides protection against existing variants, such as the Delta variant, and future SARS-CoV-2 variants.
-
Featured
Using Artificial Intelligence to Diagnose Glaucoma
David S. Friedman, MD, PhD, MPH, a clinician-scientist and director of the Glaucoma Service in the Department of Ophthalmology, discusses the implementation of artificial intelligence in the detection of glaucoma in screening with photographs.
-
Featured
Potential Treatment Targets Identified for Age-Related Macular Degeneration
By assessing genomic–metabolomic associations in age-related macular degeneration, Deeba Husain, MD, of the Department of Ophthalmology, and colleagues have obtained additional evidence of the pathogenic role of the LIPC gene and glycerophospholipid metabolism, which may represent novel treatment targets.
-
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
Ophthalmologists at Massachusetts Eye and Ear/Massachusetts General Hospital have determined that between 2013 and 2018, the number of minimally invasive glaucoma surgeries surpassed the number of conventional glaucoma surgeries, despite limited evidence of long-term safety or effectiveness.
-
Incidence of Ocular Burns Increasing in U.S.
Ophthalmologists at Massachusetts Eye and Ear/Massachusetts General Hospital found in a U.S. ophthalmology registry study that the incidence of ocular burns increased 20% between 2013 and 2017, and women and men were affected equally.
-
Gene Therapy Reverses Degeneration of the Retinal Pigment Epithelium in Preclinical Models
Gene therapy with Nrf2—a master transcription factor—preserves the retinal pigment epithelium in mouse models of retinitis pigmentosa, David M. Wu, MD, PhD, of the Department of Ophthalmology, and colleagues observed.
Ophthalmology Contributors
-
Alice C. Lorch, MD, MPH
Assistant Professor of Ophthalmology, Harvard Medical School, Associate Chief for Quality for the Department of Ophthalmology, Mass Eye and Ear, Director, Harvard Ophthalmology Residency Training Program
Recent Article
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
-
Bruce Ksander, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Janey L. Wiggs, MD, PhD
Associate Chief, Ophthalmology Clinical Research, Mass Eye and Ear, Paul Austin Chandler Professor of Ophthalmology, Harvard Medical School
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Joan W. Miller, MD
Chief, Ophthalmology Department, Massachusetts General Hospital, Chief, Ophthalmology Department, Mass Eye and Ear, Ophthalmologist-in-Chief, Brigham and Women’s Hospital
Recent Article
Minimally Invasive Glaucoma Surgery Has Been Adopted Rapidly in the U.S.
-
Lucia Sobrin, MD, MPH
Associate Chief of Clinical Data Science and Director of the Morse Laser Center, Mass Eye and Ear, Associate Professor of Ophthalmology, Harvard Medical School, Co-Director, Ocular Immunology and Uveitis Fellowship
Recent Article
Female Hormonal Therapy Makes Only Small Contribution to Risk of Noninfectious Uveitis
-
Luk Vandenberghe, PhD
Associate Professor of Ophthalmology, Harvard Medical School, Grousbeck Family Chair in Gene Therapy and Director of the Grousbeck Gene Therapy Center, Mass Eye and Ear
Recent Article
Developing a Gene-based Vaccine Candidate for COVID-19
-
Meredith Gregory-Ksander, PhD
Associate Scientist, Schepens Eye Research Institute, Mass Eye and Ear, Assistant Professor of Ophthalmology, Harvard Medical School
Recent Article
Turning Back the Clock on Aged Eye Cells
-
Milica Margeta, MD, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Genetic Risk Factor for Alzheimer's Disease Linked to Reduced Glaucoma Risk
-
Tobias Elze, PhD
Assistant Professor of Ophthalmology, Harvard Medical School, Assistant Scientist, Mass Eye and Ear
Recent Article
Central Visual Field Patterns Identified by Artificial Intelligence Improve Prediction of Glaucoma Progression
-
Ula V. Jurkunas, MD
Associate Professor of Ophthalmology, Harvard Medical School, Associate Scientist, Mass Eye and Ear
Mass Eye and Ear/Mass General Ophthalmology
An international center for ophthalmology treatment and research, Mass Eye and Ear/Massachusetts General Hospital is the primary teaching hospital of Harvard Medical School’s Department of Ophthalmology, and is consistently recognized as one of the nation’s top hospitals for eye care. Led by Chief and Chair Joan W. Miller, MD, the department provides seamless access to the most innovative care available anywhere in the world.
